XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2018 $ 219,383 $ 1 $ 551,937 $ (287) $ (332,268)
Beginning balance, Shares at Dec. 31, 2018   125,818,000      
Cumulative-effect adjustment upon adoption (ASC 842) at Dec. 31, 2018 2,693       2,693
Common stock issued upon vesting of restricted stock units, net, Shares   1,780,000      
Common stock issued upon stock option exercise 37,638   37,638    
Common stock issued upon stock option exercise, Shares   2,957,000      
Common stock issued in connection with acquisition 30,092   30,092    
Common stock issued in connection with acquisition, shares   1,944,000      
Common stock issued under employee stock purchase plan 2,662   2,662    
Common stock issued under employee stock purchase plan, shares   261,000      
Stock-based compensation expense 32,296   32,296    
Comprehensive Income (loss) 788 [1]     788  
Other 232   232    
Other, Shares   16,000      
Net loss (36,255)       (36,255)
Ending balance at Jun. 30, 2019 289,529 $ 1 654,857 501 (365,830)
Ending balance, Shares at Jun. 30, 2019   132,776,000      
Beginning Balance at Mar. 31, 2019 234,995 $ 1 582,652 (306) (347,352)
Beginning balance, Shares at Mar. 31, 2019   128,060,000      
Common stock issued upon vesting of restricted stock units, net, Shares   882,000      
Common stock issued upon stock option exercise 23,219   23,219    
Common stock issued upon stock option exercise, Shares   1,629,000      
Common stock issued in connection with acquisition 30,092   30,092    
Common stock issued in connection with acquisition, shares   1,944,000      
Common stock issued under employee stock purchase plan 2,662   2,662    
Common stock issued under employee stock purchase plan, shares   261,000      
Stock-based compensation expense 16,232   16,232    
Comprehensive Income (loss) 807 [1]     807  
Net loss (18,478)       (18,478)
Ending balance at Jun. 30, 2019 289,529 $ 1 654,857 501 (365,830)
Ending balance, Shares at Jun. 30, 2019   132,776,000      
Beginning Balance at Dec. 31, 2019 301,984 $ 1 705,143 (444) (402,716)
Beginning balance, Shares at Dec. 31, 2019   136,054,000      
Common stock issued upon vesting of restricted stock units, net 0        
Common stock issued upon vesting of restricted stock units, net, Shares   1,996,000      
Common stock issued upon stock option exercise $ 25,629   25,629    
Common stock issued upon stock option exercise, Shares 1,920,482 1,920,000      
Common stock issued under employee stock purchase plan $ 3,082   3,082    
Common stock issued under employee stock purchase plan, shares   268,000      
Stock-based compensation expense 38,459   38,459    
Comprehensive Income (loss) (889) [1]     (889)  
Net loss (47,174)       (47,174)
Ending balance at Jun. 30, 2020 321,091 $ 1 772,313 (1,333) (449,890)
Ending balance, Shares at Jun. 30, 2020   140,238,000      
Beginning Balance at Mar. 31, 2020 307,391 $ 1 737,236 (2,880) (426,966)
Beginning balance, Shares at Mar. 31, 2020   138,070,000      
Common stock issued upon vesting of restricted stock units, net 0        
Common stock issued upon vesting of restricted stock units, net, Shares   1,051,000      
Common stock issued upon stock option exercise 11,814   11,814    
Common stock issued upon stock option exercise, Shares   849,000      
Common stock issued under employee stock purchase plan 3,082   3,082    
Common stock issued under employee stock purchase plan, shares   268,000      
Stock-based compensation expense 20,181   20,181    
Comprehensive Income (loss) 1,547 [1]     1,547  
Net loss (22,924)       (22,924)
Ending balance at Jun. 30, 2020 $ 321,091 $ 1 $ 772,313 $ (1,333) $ (449,890)
Ending balance, Shares at Jun. 30, 2020   140,238,000      
[1] Net of tax effect which was not material.